Patents by Inventor Christopher M. Staley

Christopher M. Staley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
    Publication number: 20240050489
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Application
    Filed: October 12, 2023
    Publication date: February 15, 2024
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Matthew J. HAMILTON, Alexander KHORUTS, Michael J. SADOWSKY, Christopher M. STALEY
  • Compositions and methods for treatment
    Patent number: 11819523
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: November 21, 2023
    Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Matthew J. Hamilton, Alexander Khoruts, Michael J. Sadowsky, Christopher M. Staley
  • COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
    Publication number: 20210060088
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Application
    Filed: November 13, 2020
    Publication date: March 4, 2021
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Matthew J. HAMILTON, Alexander KHORUTS, Michael J. SADOWSKY, Christopher M. STALEY
  • Compositions and methods for treatment
    Patent number: 10849936
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: December 1, 2020
    Assignee: Regents of the University of Minnesota
    Inventors: Matthew J. Hamilton, Alexander Khoruts, Michael J. Sadowsky, Christopher M. Staley
  • COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
    Publication number: 20190247445
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Application
    Filed: July 3, 2017
    Publication date: August 15, 2019
    Inventors: Matthew J. HAMILTON, Alexander KHORUTS, Michael J. SADOWSKY, Christopher M. STALEY
  • COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT
    Publication number: 20180000872
    Abstract: The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
    Type: Application
    Filed: September 7, 2016
    Publication date: January 4, 2018
    Inventors: Matthew J. Hamilton, Alexander Khoruts, Michael J. Sadowsky, Christopher M. Staley